Oncotarget is a weekly publisher of peer-reviewed research papers on the subject of cancer, as well as on other Life Science topics, such as endocrinology, pathology, physiology, immunology and geriatric diseases. The medical journal, which was started in May of 2010, covers all aspects of oncology research, and it is very popular among scientists who study cancer with the hopes of finding a way to eradicate the disease completely.
Research papers that are submitted to Oncotarget become available online in PubMed or Medline within 2 to 5 days after they are accepted by the journal’s editors, who evaluate all manuscripts on the basis of how thorough they are and how much they will contribute to helping others learn more about what has been discovered through different cancer research efforts. The editor of the journal relies on peer reviews in order to make decisions on which papers to publish, and to provide advice to the authors of the papers on how they can improve their writings. Check the journal at SCImago Journal & Country Rank.
In order for papers to be considered for publishing, authors have to be accurate when describing their findings, and they have to be able to discuss their work from an objective standpoint. Oncotarget puts out two issues of their publication a week, and it can be accessed for free. Their mission is to make cancer research results available in a faster way that will also reach more people who have a deep interest in the scientific studies of the major disease.
To further their informational reporting on the study of oncology and Life Science topics, Oncotarget launched a new podcast in November of this year that can be accessed on Stitcher, Player.FM and iTunes. The intent of the podcast is to allow researchers to go further in depth with the research results that were published in the journal. It helps subscribers gain more access to the most important findings in the journal through readings of the published papers, as well as interviews with the best authors and readings that were selected from Oncotarget’s blog. Follow Oncotarget journal on Twitter.
Oncotarget follows a strict code of conduct and doesn’t discriminate on the basis of race, gender, citizenship or sexual orientation when it comes to authors’ research paper contributions.